Friedman H, Seckman C, Lanza F, Royer G, Perry K, Francom S
Clinical Pharmacology Unit, Upjohn Company, Kalamazoo, Michigan 49001.
J Clin Pharmacol. 1990 Jan;30(1):57-63. doi: 10.1002/j.1552-4604.1990.tb03439.x.
Thirty-five healthy adults were randomized to receive either: (1) ibuprofen 800 mg tablets; (2) ibuprofen 800 mg aqueous suspension; (3) ibuprofen 800 mg orange juice suspension; or (3) 325 mg aspirin tablets. All treatments were tid for 7 days. Pharmacokinetic sampling was conducted on days 1, 4 and 8. Gastroduodenoscopy was performed on days 1 and 8. Side effects and safety laboratory tests were monitored throughout the study. On day 8 the aspirin group showed significantly more gastric irritation than all of the ibuprofen groups (P less than .005). Both ibuprofen suspension groups showed more gastric irritation than the ibuprofen tablet group (P less than .1). The duodenal scores did not differ among the treatment groups. The aspirin group experienced a higher rate of tinnitus and abdominal pain. The rate and extent of absorption of the ibuprofen suspensions were significantly less than that of the tablets. These data suggest that the taking of ibuprofen as an extemporaneous suspension is therapeutically inferior to ibuprofen tablets and therefore should be discouraged.
35名健康成年人被随机分为四组,分别接受以下治疗:(1)800毫克布洛芬片剂;(2)800毫克布洛芬水混悬液;(3)800毫克布洛芬橙汁混悬液;(4)325毫克阿司匹林片剂。所有治疗均每日三次,持续7天。在第1、4和8天进行药代动力学采样。在第1和8天进行胃十二指肠镜检查。在整个研究过程中监测副作用和安全性实验室检查。在第8天,阿司匹林组的胃部刺激明显多于所有布洛芬组(P<0.005)。两个布洛芬混悬液组的胃部刺激均多于布洛芬片剂组(P<0.1)。各治疗组之间十二指肠评分无差异。阿司匹林组耳鸣和腹痛的发生率较高。布洛芬混悬液的吸收速率和程度明显低于片剂。这些数据表明,临时配制的布洛芬混悬液在治疗上不如布洛芬片剂,因此应不鼓励使用。